References
- Andersen, O. (2004). Chemical and biological considerations in the treatment of metal intoxication by chelating agents. Mini Rev Med Chem. 4, 11–21.
- Andersen, O., Aaseth, J. (2002). Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications. Environ Health Persp. 110 (suppl 5), 887–90.
- Barrow, D.J. Jr., Chandrasekaran, S., Heerklotz, H.H., Henary, M.M., Michniak, B.B., Nguyen, P.M., Song, Y., Smith, J.C., Strekowski, L. (2005). Mechanistic studies on percutaneous penetration enhancement by N-(4-halobenzoyl)-S,S-dimethyliminosulfuranes. J Lipid Res. 46, 2192–201.
- Blanusa, M., Varnai, V.M., Piasek, M., Kostial, K. (2005). Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem. 12, 2771–94.
- Chandrasekaran, S.K., Shaw, J.E. (1978). Factors influencing the percutaneous absorption of drugs. Curr Probl Dermatol. 7, 142–55.
- Dimitrijevic, D., Shaw, A.J., Florence, A.T. (2000). Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J Pharm Pharmacol. 52, 157–62.
- Eley, J.G., Triumalashetty, P. (2001). In vitro assessment of alkyglycosides as permeability enhancers. AAPS PharmsciTech. 2, 1–7.
- Grass, G.M., Wood, R.W., Robinson, J.R. (1985). Effect of calcium chelating agents on corneal permeability. IOVS. 26, 110–3.
- He, X., Hahn, P., Iacovelli, J., Wong, R, King, C, Bhisitkul, R, Massaro-Giordano, M, Dunaief, JL. (2007). Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 26, 649–73.
- Horváth, K., Noker, P.E., Somfai-Relle, S., Glávits, R., Financsek, I., Schauss, A.G. (2002). Toxicology of methylsulfonylmethane in rats. Food Chem Toxicol. 40, 1459–62.
- Jayasena, T., Grant, R.S., Keerthisinghe, N., Solaja, I., Smythe, G.A. (2007). Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells. Neurosci Res. 57, 454–61.
- Kalinowsky, D.S., Richardson, D.R. (2005). The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev. 57, 547–83.
- Liu, G., Men, P., Harris, P.L., Rolston, R.K., Perry, G., Smith, M.A. (2006). Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurological disorders associated with trace metal imbalance. Neurosci Lett. 406, 189–93.
- Magnuson, B.A., Appleton, J., Ames, G.B. (2007). Pharmacokinetics and distribution of (35S) methylsulfonylmethane follow oral administration to rats. J Agric Food Chem. 55, 1033–8.
- Meaney, C.M., O’Driscoll, C.M. (2000). A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model. Int J Pharm. 207, 21–30.
- Najjar, D.M., Cohen, E.J., Rauan, C.J., Laaibson, P.R. (2004). EDTA chelation for calcific band keratopathy: results and long-term follow-up. Am J Ophthalmol. 137, 1056–64.
- Ouyang, H., Morris-Natschke, S.L., Ishaq, K.S., Ward, P., Liu, D., Leonard, S., Thakker, D.R. (2002). Structure-activity relationship for enhancement of paracellular permeability across Caco-2 cell monolayers by 3-alkylamido-2-alkoxypropylphosphocholines. J Med Chem. 45, 2857–66.
- Quan, Y.S., Hattori, K., Lundborg, E., Fujita, T., Murakami, M., Muranishi, S., Yamamoto, A. (1998). Effectiveness and toxicitiy screening of various absorption enhancers using Caco-2 cell monolayers. Biol Pharm Bull. 21, 615–20.
- Sakai, M., Imai, T., Ohtake, H., Otagiri, M. (1998). Cytotoxicity of absorption enhancers in Caco-2 monolayers. J Pharm Pharmacol. 50, 1101–8.
- Smith, J., Wood, E., Dornish, M. (2004). Effect of chitosan on epithelial cell tight junctions. Pharm Res. 21, 43–9.
- Swenson, E.S., Milisen, W.B., Curatolo, W. (1994). Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res. 11, 1132–42.
- Uchiyama, T., Yamamoto, A., Hatano, H., Fujita, T., Muranishi, S. (1996). Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane. Biol Pharm Bull. 19, 1618–21.